Posted in | News | Nanomaterials

REACH Implementation Projects on Nanomaterials Publishes Final Reports

Final reports have been published from two REACH Implementation Projects on Nanomaterials (RIP-oN 2&3). Commissioned by the JRC's Institute for Health & Consumer Protection, the projects intended to develop specific advice on the implementation of REACH for nanomaterials.

The outputs from the projects have been developed over a period of 12-16 months in consultation with a range of stakeholders. The reports have scoped the current state-of-the-science regarding assessment of nanomaterials in the context of REACH, and provide recommendations to the European Commission on how the REACH Guidance on Information Requirements and Chemical Safety Assessment could be further developed to better address nanomaterials.

The RIP-oN 2 project has addressed the REACH information requirements on intrinsic properties of nanomaterials, and the information needed for safety evaluation of nanomaterials. The RIP-oN 3 project has addressed exposure assessments and hazard and risk characterisation for nanomaterials within the REACH context.

The projects were undertaken by a consortium led by SAFENANO at the Institute of Occupational Medicine and involving the European Chemical Industry Council (Cefic), the Nanotechnology Industries Association (NIA), and Soluzioni Informatiche, which brought together internationally renowned experts from disciplines including physical sciences, life sciences, occupational hygiene, and risk assessment.

The final reports can be downloaded from the DG Environment webpage at http://ec.europa.eu/environment/chemicals/nanotech/index.htm#ripo:n

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.